Differential Sensitivity of p53(-) and p53(+) Cells to Caffeine-induced Radiosensitization and Override of G2 Delay

作者: Frederic Preffer , David Dombkowski , Jeffrey S. DeFrank , Stephen Friend , Simon N. Powell

DOI:

关键词:

摘要: Most drug discovery efforts have focused on finding new DNA-damaging agents to kill tumor cells preferentially. An alternative approach is find ways increase tumor-specific killing by modifying responses that damage. In this report, we ask whether lacking the G1-S arrest in response X-rays are more sensitive X-ray damage when treated with override G2-M arrest. Mouse embryonic fibroblasts genetically matched be (+) or (-) p53 and rat for wild-type function were irradiated without caffeine, a known checkpoint inhibitor. At low doses (500 µm), caffeine caused selective radiosensitization p53(-) cells. dose (where no effect was seen p53(+) cells), showed 50% reduction size of higher (2 mm caffeine), where sensitization both cells, pronounced The greater caffeine-induced suggests p53, already shown control checkpoint, may also influence aspects These data indicate an opportunity therapeutic gain combining compounds disrupt tumors functional p53.

参考文章(20)
Amanda J. McIlwrath, Robert Brown, Paul A. Vasey, Gillian M. Ross, Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Research. ,vol. 54, pp. 3718- 3722 ,(1994)
Kurt W. Kohn, Joany Jackman, Ian Magrath, Kishor Bhatia, Daniel Jondle, Patrick M. O'Connor, Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines Cancer Research. ,vol. 53, pp. 4776- 4780 ,(1993)
M S Greenblatt, W P Bennett, M Hollstein, C C Harris, Mutations in the p53 Tumor Suppressor Gene: Clues to Cancer Etiology and Molecular Pathogenesis Cancer Research. ,vol. 54, pp. 4855- 4878 ,(1994)
K. W. Kohn, D. J. Rivet, A. J. Fornace, Qimin Zhan, M. L. Smith, Saijun Fan, P. M. O'connor, D. Duba, Disruption of p53 Function Sensitizes Breast Cancer MCF-7 Cells to Cisplatin and Pentoxifylline Cancer Research. ,vol. 55, pp. 1649- 1654 ,(1995)
Bert Vogelstein, David Sidransky, Ruth W. Craig, Michael B. Kastan, Onyinye Onyekwere, Participation of p53 Protein in the Cellular Response to DNA Damage Cancer Research. ,vol. 51, pp. 6304- 6311 ,(1991)
P. R. Andreassen, R. L. Margolis, 2-Aminopurine overrides multiple cell cycle checkpoints in BHK cells. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 2272- 2276 ,(1992) , 10.1073/PNAS.89.6.2272
Michael B. Kastan, Qimin Zhan, Wafik S. El-Deiry, France Carrier, Tyler Jacks, William V. Walsh, Beverly S. Plunkett, Bert Vogelstein, Albert J. Fornace, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia Cell. ,vol. 71, pp. 587- 597 ,(1992) , 10.1016/0092-8674(92)90593-2
Francisco S. Pardo, Mei Su, Carmia Borek, Fred Preffer, David Dombkowski, Leo Gerweck, Emmett V. Schmidt, Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiation Research. ,vol. 140, pp. 180- 185 ,(1994) , 10.2307/3578901
S. J. Kuerbitz, B. S. Plunkett, W. V. Walsh, M. B. Kastan, Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 7491- 7495 ,(1992) , 10.1073/PNAS.89.16.7491